ArticleBMC medicine2025

Ad5-boosted COVID-19 vaccine reduces symptomatic BA.5 infection via cross-neutralizing antibodies and NK cell immunity.

Tingting Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.